{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:44:54Z","timestamp":1781664294325,"version":"3.54.5"},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.5414\/cpp39529","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T04:40:05Z","timestamp":1301028005000},"page":"529-533","source":"Crossref","is-referenced-by-count":6,"title":["Montelukast and improvement of eczema: observations from a prescription event monitoring study in England"],"prefix":"10.5414","volume":"39","author":[{"given":"P.","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.V.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.W.","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T06:24:58Z","timestamp":1378448698000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=6054&doi=10.5414\/CPP39529&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001]]}},"alternative-id":["39529"],"URL":"https:\/\/doi.org\/10.5414\/cpp39529","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}